Orthofix International reported $221.59M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.42M 148.07M Jun/2026
AtriCure USD 61M 0 Jun/2026
Dexcom USD 1.3B 200K Jun/2026
EDAP TMS EUR 17.6M 16.6M Mar/2026
Globus Medical USD 398K 38K Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
J&J USD 37.34B 183M Jun/2026
Medtronic USD 27.88B 255M Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 221.59M 256K Jun/2026
Plus Therapeutics USD 3.79M 322K Dec/2022
Smith & Nephew USD 3.21B 85M Jun/2026
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Veracyte USD 0 0 Mar/2025
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026